CCC | MedPage Today
Crohn's & Colitis Congress
Stay updated with breaking news from Specific Carbohydrate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First interchangeable biosimilar approved, biologics go head-to-head
This article is a collaboration between MedPage Today and: Both the Mediterranean diet and the Specific Carbohydrate diet were effective for symptom reduction in patients with Crohn's disease, a randomized clinical trial demonstrated. At week 6, symptomatic remission was achieved by 44% of patients on the Mediterranean diet and by 47% of those following the Specific Carbohydrate diet, reported James D. Lewis, MD, of the University of Pennsylvania in Philadelphia at the virtual Crohn's and Colitis Congress. And clinical remission defined by the Crohn's Disease Activity Index also was observed...